EE427 Annual Cost Savings From the Use of Empagliflozin Over DPP4I in Select Asia-Pacific Countries – Estimates Based on the Emprise East Asia Study von Varghese, L, Alcantara, G, Germanos, P, Sumettavanich, Y, Das, A, Gordon, J

Volltext